1. Adams GE, Clarke ED, Flockhart IR, Jacobs RS, Sehmi DS, Stratford IJ, Wardman P and Watts ME. Structure-activity relationships in the development of hypoxic cell radiosensitizers. Int. J. Radiat. Biol. 35, 133–150 (1979).
2. Adams GE, Clarke ED, Jacobs RS, Stratford IJ, Wallace RG, Wardman P and Watts ME. Mammalian cell toxicity of nitro compounds: dependence upon reduction potential. Biochem. Biophys. Res. Commun. 72, 824–829 (1976a).
3. Adams GE, Flockhart IR, Smithen CE, Stratford IJ, Wardman P and Watts ME. Electron-affinic sensitization VII. A correlation between structures, one-electron potentials and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat. Res. 67, 9–20 (1976b).
4. Al-Arafaj A, Ryan EA, Hutchinson K, Mannan RH, Mercer J, Wiebe LI and McEwan AJB. An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus. Eur. J. Nucl. Med. 21, 1338–1342 (1994).
5. Betageri GV and Rogers JA. Correlation of partitioning nitroimidazoles in the n-octanol/saline and liposome systems with pharmacokinetic parameters and quantitative structure-activity relationships (QSAR). Pharmaceut. Res. 6, 399–403 (1989).